London: A simple blood test could tell whether the commonest form of breast cancer will recur post therapy, sparing women unwanted treatment with anti-cancer drugs.
"If we can accurately predict which women are at high risk of breast cancer recurrence, it gives the physicians and oncologists treating these women time to design a more aggressive therapy in the hopes of preventing the cancer from coming back," said researcher Sambasivarao Damaraju, from University of Alberta, Canada.
